6741 - 6750 of 8826 Results
Title
Year
-
OPENTitle: A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 78Issue #: 16Start Page: 1229End Page: 1236Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182516244Best OA location URL: https://n.neurology.org/content/neurology/78/16/1229.full.pdfCitation Count: 331
-
OPENTitle: Crowdsourcing digital health measures to predict Parkinson’s disease severity: the Parkinson’s Disease Digital Biomarker DREAM ChallengeJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page: 53End Page: 53Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41746-021-00414-7Best OA location URL: https://www.nature.com/articles/s41746-021-00414-7.pdfCitation Count: 61
-
OPENTitle: Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of AgingJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 84Issue #: 14Start Page: 1433End Page: 1442Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000001437Best OA location URL: https://n.neurology.org/content/neurology/84/14/1433.full.pdfCitation Count: 149
-
OPENTitle: Effect of Urate-Elevating Inosine on Early Parkinson Disease ProgressionJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 326Issue #: 10Start Page: 926End Page: 926Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2021.10207Best OA location URL: https://jamanetwork.com/journals/jama/articlepdf/2784144/jama_schwarzschild_2021_oi_210070_1631212847.50479.pdfCitation Count: 154
-
OPENTitle: Association of vitamin K with cognitive decline and neuropathology in community‐dwelling older personsJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/trc2.12255Best OA location URL: https://doi.org/10.1002/trc2.12255Citation Count: 47
-
OPENTitle: Shared and disease-specific pathways in frontotemporal dementia and Alzheimer’s and Parkinson’s diseasesJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 31Issue #: 8Start Page: 2567End Page: 2577Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41591-025-03833-1Best OA location URL: https://www.nature.com/articles/s41591-025-03833-1.pdfCitation Count: 19
-
OPENTitle: Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD studyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page: 64End Page: 64Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00497-xBest OA location URL: https://www.nature.com/articles/s41531-023-00497-x.pdfCitation Count: 87
-
OPENTitle: Vesicular dysfunction and pathways to neurodegenerationJournal Name: Essays in BiochemistryPublisher: Portland Press Ltd.Vol: 65Issue #: 7Start Page: 941End Page: 948Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1042/ebc20210034Best OA location URL: https://portlandpress.com/essaysbiochem/article-pdf/65/7/941/929366/ebc-2021-0034c.pdfCitation Count: 13
- Men with FMR1 premutation alleles of less than 71 CGG repeats have low risk of being affected with fragile X-associated tremor/ataxia syndrome (FXTAS)2021RESTRICTEDTitle: Men with FMR1 premutation alleles of less than 71 CGG repeats have low risk of being affected with fragile X-associated tremor/ataxia syndrome (FXTAS)Journal Name: Journal of Medical GeneticsPublisher: BMJVol: 59Issue #: 7Start Page: 706End Page: 709Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/jmedgenet-2021-107758Citation Count: 6
- Faster disease progression in Parkinson’s disease with type 2 diabetes is not associated with increased α‐synuclein, tau, amyloid‐β or vascular pathology2021OPENTitle: Faster disease progression in Parkinson’s disease with type 2 diabetes is not associated with increased α‐synuclein, tau, amyloid‐β or vascular pathologyJournal Name: Neuropathology and Applied NeurobiologyPublisher: WileyVol: 47Issue #: 7Start Page: 1080End Page: 1091Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/nan.12728Citation Count: 42